All In Biotech

Drug Trial Radar · NCT03054285

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

Last checked: Nov 19, 2026Latest source record: Aug 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 2,300 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,300

Planned (sponsor's estimate)

Start

Jul 1, 2017

Primary completion

Apr 1, 2020

Study completion Apr 1, 2021

Sponsor

Lead sponsor
Loyola UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 15, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to prospectively assess in randomized fashion whether short term anti-seizure prophylaxis in traumatic brain injured patients decreases the incidence of seizures in the early post-injury period. A secondary objective is to evaluate whether there are differences in mortality, hospital length of stay, functional outcome at hospital discharge, hospital cost, discharge status (home, rehabilitation facility, etc.) for patients who receive and do not receive anti-seizure prophylaxis.

Conditions

  • Seizures
  • Traumatic Brain Injury

Interventions

  • LevetiracetamDrug

    Participants assigned to the experimental arm will receive a seven day course of levetiracetam for post-traumatic brain injury

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seizures (count of seizures)Time frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Loyola University Medical Center

    Maywood, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.